Effects of Poloxamer 188 on red blood cell membrane properties in sickle cell anaemia

被引:22
|
作者
Sandor, Barbara [1 ]
Marin, Mickael [2 ,3 ,4 ]
Lapoumeroulie, Claudine [2 ,3 ,4 ]
Rabai, Miklos [1 ]
Lefevre, Sophie D. [2 ,3 ,4 ,5 ]
Lemonne, Nathalie [6 ]
El Nemer, Wassim [2 ,3 ,4 ]
Mozar, Anais [4 ,7 ]
Francais, Olivier [8 ]
Le Pioufle, Bruno [8 ]
Connes, Philippe [4 ,7 ,8 ,9 ,10 ]
Le van Kim, Caroline [2 ,3 ,4 ,5 ]
机构
[1] Univ Pecs, Sch Med, Pecs, Hungary
[2] INSERM, UMR S1134, Paris, France
[3] Inst Natl Transfus Sanguine, F-75015 Paris, France
[4] Lab Excellence GR Ex, Paris, France
[5] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France
[6] CHU Pointe A Pitre, Pointe A Pitre, Guadeloupe, France
[7] Univ Antilles Guyane, INSERM, Pointe A Pitre 97159, Guadeloupe, France
[8] Ecole Normale Super, BIOMIS SATIE, CNRS, UMR 8029, Cachan, France
[9] Univ Lyon 1, Sect Vasc Biol & Red Blood Cell, Lab CRIS EA647, F-69365 Lyon, France
[10] Inst Univ France, Paris, France
关键词
sickle cell anaemia; poloxamer; red blood cell; AGGREGATION; ENDOTHELIUM; INHIBITION; VISCOSITY; ADHESION;
D O I
10.1111/bjh.13937
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vaso-occlusive crisis (VOC) is the main acute complication in sickle cell anaemia (SS) and several clinical trials are investigating different drugs to improve the clinical severity of SS patients. A phase III study is currently exploring the profit of Velopoloxamer in SS during VOCs. We analysed, in-vitro, the effect of poloxamer (P188) on red blood cell (RBC) properties by investigating haemorheology, mechanical and adhesion functions using ektacytometry, microfluidics and dynamic adhesion approaches, respectively. We show that poloxamer significantly reduces blood viscosity, RBC aggregation and adhesion to endothelial cells, supporting the beneficial use of this molecule in SS therapy.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 50 条
  • [1] Evaluation of Purified Poloxamer-188 (vepoloxamer) on Sickle Red Blood Cell (RBC) Membrane Function Properties
    White, Jennell
    Hines, Patrick C.
    Liu, Ke
    Benjamin, Lennette J.
    Gao, Xiufeng
    Emanuele, Martin
    BLOOD, 2015, 126 (23)
  • [2] Poloxamer 188 for Sickle Cell Disease
    Zylke, Jody
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15): : 1524 - 1524
  • [3] Microcirculatory effects of Poloxamer 188 in transgenic sickle cell mice.
    Hsu, LL
    Liu, XW
    Pierangeli, S
    Eckman, JR
    Aguayo, SM
    Jack, D
    Wick, TM
    BLOOD, 2002, 100 (11) : 664A - 664A
  • [4] The Effect of Glucose and Poloxamer 188 on Red-Blood-Cell Aggregation
    Szolna-Chodor, Alicja
    Grzegorzewski, Bronislaw
    METABOLITES, 2021, 11 (12)
  • [5] Blood Thixotropy in Patients with Sickle Cell Anaemia: Role of Haematocrit and Red Blood Cell Rheological Properties
    Vent-Schmidt, Jens
    Waltz, Xavier
    Romana, Marc
    Hardy-Dessources, Marie-Dominique
    Lemonne, Nathalie
    Billaud, Marie
    Etienne-Julan, Maryse
    Connes, Philippe
    PLOS ONE, 2014, 9 (12):
  • [6] Inhibition of polymer-induced red blood cell aggregation by poloxamer 188
    Toth, K
    Wenby, RB
    Meiselman, HJ
    BIORHEOLOGY, 2000, 37 (04) : 301 - 312
  • [7] Purified poloxamer 188 for sickle cell vaso-occlusive crisis
    Gibbs, WJ
    Hagemann, TM
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) : 320 - 324
  • [8] Effects of pyruvate kinase activators on red blood cell properties in sickle cell disease
    Joly, Philippe
    Nader, Elie
    Ketels, Flora
    Boisson, Camille
    Carin, Romain
    Renoux, Celine
    Gauthier, Alexandra
    Poutrel, Solene
    Bertrand, Yves
    Connes, Philippe
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (04) : E27 - E30
  • [9] PATTERNS OF RED CELL DESTRUCTION IN SICKLE-CELL ANAEMIA
    HATHORN, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1967, 13 (05) : 746 - &
  • [10] HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia
    Rodrigues, C.
    Sell, A. M.
    Guelsin, G. A. S.
    Higa, T. T.
    Pagliarini e Silva, S.
    Macedo, L. C.
    Sippert, E. A.
    de Alencar, J. B.
    Zanette, A.
    Acorsi, C. R. L.
    Castilho, L.
    Visentainer, J. E. L.
    TRANSFUSION MEDICINE, 2017, 27 (06) : 437 - 443